Profilo
Michael N.
Avallone has been Chief Financial Officer of AMAG Pharmaceuticals, Inc. since joining the company in July 2004 and Vice President of Finance since August 2004.
From 2000 to 2004, Mr. Avallone worked at Boston Biomedica, Inc., including as Corporate Controller and Vice President of Finance and Chief Financial Officer.
He held various executive positions in accounting and finance at affiliates of NSTAR.
Precedenti posizioni note di Michael N. Avallone
| Società | Posizione | Fine |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 21/03/2007 |
| PRESSURE BIOSCIENCES, INC. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael N. Avallone
